Skip to main content

Notice

We are in the process of rolling out a soft launch of the RDA website, which includes a new member platform. Existing RDA members PLEASE REACTIVATE YOUR ACCOUNT using this link: https://rda-login.wicketcloud.com/users/confirmation. Visitors may encounter functionality issues with group pages, navigation, missing content, broken links, etc. As you explore the new site, please provide your feedback using the UserSnap tool on the bottom right corner of each page. Thank you for your understanding and support as we work through all issues as quickly as possible. Stay updated about upcoming features and functionalities: https://www.rd-alliance.org/rda-web-platform-upcoming-features-and-functionalities/

#129522

Hi Hugh,
I agree with the approach you propose. Personally I would list both yourself and Claire Austin to round out the list of three authors in light of your extensive work in drafting the document.
I would also broach the topic of a longer (i.e. everyone) list of authors with the editors in the submission letter or supplementary documentation.
Best,
Alex
Sent from Mail for Windows 10
– Show quoted text -From: hughshanahan via RDA COVID19 Coordination
Sent: March 25, 2021 3:30 PM
To: ***@***.***-groups.org; Zoe Cournia; ***@***.***; ***@***.***-foundation.org; ***@***.***-foundation.org
Subject: [rdacovid19-coordination] Re: [EXT] [rdacovid19-coordination] RDA COVID-19 WG Response to Nature Commentary-writing sprint to finalize
Dear all
the text of the correspondence to Nature has been finalised and can be found here . To note the correspondence text is supposed to be 250 words and the accompanying text (all sent by email) is 100 words. If possible please send comments by 12:00 Eastern Time. A few points to make here
* guidelines on this is for three authors and it cannot be from an organisation. I propose that Hilary be the single author representing the RDA (we could have the chairs of the WG instead but that is six names then).
* I need to be clear that the situation is moving quite rapidly and we should get this out the door by EOB tomorrow. Additional commentaries are coming in o Nature which necessitates changes in the text. Today we needed to do a more or less complete rewrite in the light of a new commentary published in Nature this week. Given that, being blunt, there is a limited chance of success here (a non-zero probability but let us say closer to 0 than 1) and that as time passes that chance gets smaller, it’s not in our interest to agonise over this text. Hence I politely request minor rather than major amendments.
All the best
Hugh
From: ***@***.***-groups.org on behalf of Mary O’Brien Uhlmansiek
Sent: 24 March 2021 15:54
To: ***@***.***-groups.org ; Zoe Cournia ; ***@***.***
Subject: [EXT] [rdacovid19-coordination] RDA COVID-19 WG Response to Nature Commentary-writing sprint to finalize
When: 25 March 2021 17:05-18:00.
Where: https://us02web.zoom.us/j/85260057706?pwd=ZTBqY1FPY3N5RWloUDFiR3Vla0dQdz09
All – we had to go with the 2nd scheduling option due to a conflict that has arisen – we hope you are still able to attend. Note I have the meeting starting at 5 minutes after the hour, in case a Zoom call scheduled immediately before this one runs over by a few minutes.
For those able to attend, we will have a writing sprint at this meeting, with a goal of finalizing the abbreviated response.
* Collaborative notes: https://docs.google.com/document/d/1zdEQyul0pWX4Mo2KsATERerLzj6SxU4F9LAE
* Response draft: https://docs.google.com/document/d/1tWEz_N–b4gqU2wD7jSj2E8KVTCfLvsoQ4ai
RDA Secretariat is inviting you to a scheduled Zoom meeting.
Join Zoom Meeting
https://us02web.zoom.us/j/85260057706?pwd=ZTBqY1FPY3N5RWloUDFiR3Vla0dQdz09
Meeting ID: 852 6005 7706
Passcode: 154027
One tap mobile
+19292056099,,85260057706#,,,,*154027# US (New York)
+13017158592,,85260057706#,,,,*154027# US (Washington DC)
Dial by your location
+1 929 205 6099 US (New York)
+1 301 715 8592 US (Washington DC)
+1 312 626 6799 US (Chicago)
+1 669 900 6833 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)
+44 203 901 7895 United Kingdom
+44 131 460 1196 United Kingdom
+44 203 051 2874 United Kingdom
+44 203 481 5237 United Kingdom
+44 203 481 5240 United Kingdom
Meeting ID: 852 6005 7706
Passcode: 154027
Find your local number: https://us02web.zoom.us/u/kcoy0EaSog
This email, its contents and any attachments are intended solely for the addressee and may contain confidential information. In certain circumstances, it may also be subject to legal privilege. Any unauthorised use, disclosure, or copying is not permitted. If you have received this email in error, please notify us and immediately and permanently delete it. Any views or opinions expressed in personal emails are solely those of the author and do not necessarily represent those of Royal Holloway, University of London. It is your responsibility to ensure that this email and any attachments are virus free.
Hi Hugh,
I agree with the approach you propose. Personally I would list both yourself and Claire Austin to round out the list of three authors in light of your extensive work in drafting the document.
I would also broach the topic of a longer (i.e. everyone) list of authors with the editors in the submission letter or supplementary documentation.
Best,
Alex
Sent from Mail for Windows 10
From: hughshanahan via RDA COVID19 Coordination
Sent: March 25, 2021 3:30 PM
To: ***@***.***-groups.org; Zoe Cournia; ***@***.***; ***@***.***-foundation.org; ***@***.***-foundation.org
Subject: [rdacovid19-coordination] Re: [EXT] [rdacovid19-coordination] RDA COVID-19 WG Response to Nature Commentary-writing sprint to finalize
Dear all
the text of the correspondence to Nature has been finalised and can be found here . To note the correspondence text is supposed to be 250 words and the accompanying text (all sent by email) is 100 words. If possible please send comments by 12:00 Eastern Time. A few points to make here
* guidelines on this is for three authors and it cannot be from an organisation. I propose that Hilary be the single author representing the RDA (we could have the chairs of the WG instead but that is six names then).
* I need to be clear that the situation is moving quite rapidly and we should get this out the door by EOB tomorrow. Additional commentaries are coming in o Nature which necessitates changes in the text. Today we needed to do a more or less complete rewrite in the light of a new commentary published in Nature this week. Given that, being blunt, there is a limited chance of success here (a non-zero probability but let us say closer to 0 than 1) and that as time passes that chance gets smaller, it’s not in our interest to agonise over this text. Hence I politely request minor rather than major amendments.
All the best
Hugh
– Show quoted text -From: ***@***.***-groups.org on behalf of Mary O’Brien Uhlmansiek
Sent: 24 March 2021 15:54
To: ***@***.***-groups.org ; Zoe Cournia ; ***@***.***
Subject: [EXT] [rdacovid19-coordination] RDA COVID-19 WG Response to Nature Commentary-writing sprint to finalize
When: 25 March 2021 17:05-18:00.
Where: https://us02web.zoom.us/j/85260057706?pwd=ZTBqY1FPY3N5RWloUDFiR3Vla0dQdz09
All – we had to go with the 2nd scheduling option due to a conflict that has arisen – we hope you are still able to attend. Note I have the meeting starting at 5 minutes after the hour, in case a Zoom call scheduled immediately before this one runs over by a few minutes.
For those able to attend, we will have a writing sprint at this meeting, with a goal of finalizing the abbreviated response.
* Collaborative notes: https://docs.google.com/document/d/1zdEQyul0pWX4Mo2KsATERerLzj6SxU4F9LAE
* Response draft: https://docs.google.com/document/d/1tWEz_N–b4gqU2wD7jSj2E8KVTCfLvsoQ4ai
RDA Secretariat is inviting you to a scheduled Zoom meeting.
Join Zoom Meeting
https://us02web.zoom.us/j/85260057706?pwd=ZTBqY1FPY3N5RWloUDFiR3Vla0dQdz09
Meeting ID: 852 6005 7706
Passcode: 154027
One tap mobile
+19292056099,,85260057706#,,,,*154027# US (New York)
+13017158592,,85260057706#,,,,*154027# US (Washington DC)
Dial by your location
+1 929 205 6099 US (New York)
+1 301 715 8592 US (Washington DC)
+1 312 626 6799 US (Chicago)
+1 669 900 6833 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)
+44 203 901 7895 United Kingdom
+44 131 460 1196 United Kingdom
+44 203 051 2874 United Kingdom
+44 203 481 5237 United Kingdom
+44 203 481 5240 United Kingdom
Meeting ID: 852 6005 7706
Passcode: 154027
Find your local number: https://us02web.zoom.us/u/kcoy0EaSog
This email, its contents and any attachments are intended solely for the addressee and may contain confidential information. In certain circumstances, it may also be subject to legal privilege. Any unauthorised use, disclosure, or copying is not permitted. If you have received this email in error, please notify us and immediately and permanently delete it. Any views or opinions expressed in personal emails are solely those of the author and do not necessarily represent those of Royal Holloway, University of London. It is your responsibility to ensure that this email and any attachments are virus free.